NEXTBio Capital Management LP Q4 2025 Filing

Filed February 13, 2026

Portfolio Value

$170.5M

Holdings

23

Report Date

Q4 2025

Filing Type

13F-HR

All Holdings (23 positions)

#StockSharesValue% PortfolioType
1
TERNTERNS PHARMACEUTICALS INC
551,190$22.3M13.06%
2
PTGXPROTAGONIST THERAPEUTICS INC
229,619$20.1M11.76%
3
VORVOR BIOPHARMA INC
999,967$13.1M7.67%
4
ZBIOZENAS BIOPHARMA INC
321,983$11.7M6.86%
5
STTKSHATTUCK LABS INC
3,149,907$11.5M6.74%
6
VSTMVERASTEM INC
1,307,330$10.1M5.92%
7
PVLAPALVELLA THERAPEUTICS INC NE
82,686$8.7M5.08%
8
XENEXENON PHARMACEUTICALS INC
183,704$8.2M4.83%
9
RYTMRHYTHM PHARMACEUTICALS INC
67,586$7.2M4.24%
10
GPCRSTRUCTURE THERAPEUTICS INC
94,443$6.6M3.85%
11
IVAINVENTIVA SA
1,298,701$6.0M3.54%
12
CMPXCOMPASS THERAPEUTICS INC
1,114,005$6.0M3.51%
13
CMPSCOMPASS PATHWAYS PLC
752,631$5.2M3.05%
14
ORICORIC PHARMACEUTICALS INC
615,720$5.0M2.95%
15
CBIOCRESCENT BIOPHARMA INC.
372,856$4.4M2.59%
16
PCVXVAXCYTE INC
95,485$4.4M2.58%
17
EVMNEVOMMUNE INC
228,286$3.9M2.29%
18
COGTCOGENT BIOSCIENCES INC
95,819$3.4M2.00%
19
IRONDISC MEDICINE INC
42,778$3.4M1.99%
20
OCSOCULIS HOLDING AG
149,750$3.0M1.75%
21
ZLABZAI LAB LTD
163,362$2.9M1.69%
22
KALVKALVISTA PHARMACEUTICALS INC
131,796$2.1M1.25%
23
ACETADICET BIO INC
157,827$1.3M0.78%